Vietnam Distributor Of Indian Drug Asked To Atone For 22 Blindnesses
This article was originally published in PharmAsia News
The Vietnam distributor of an Indian drug maker's eye drug has been requested to make amends for 22 patients blinded by the drug used in cataract surgeries
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.